Previous Close | 2.1300 |
Open | 2.0400 |
Bid | 1.9000 x 1400 |
Ask | 2.1700 x 800 |
Day's Range | 1.9300 - 2.1000 |
52 Week Range | 1.5600 - 10.9400 |
Volume | |
Avg. Volume | 1,022,317 |
Market Cap | 93.922M |
Beta (5Y Monthly) | -0.17 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -2.3100 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 5.00 |
NATICK, Mass., May 02, 2024--Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced three oral scientific presentations at the 12th Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders – European Chapter (IFSO-EC) held in Vienna, Austria on 2-4 May 2024.
NATICK, Mass., April 30, 2024--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced preliminary, unaudited results for the first quarter 2024. Management expects preliminary unaudited results for the period as follows:
NATICK, Mass., April 17, 2024--Allurion Closes $48 Million Convertible Senior Secured Note Financing with RTW Investments